Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124176373 | 12417637 | 3 | F | 201601 | 20160802 | 20160530 | 20160811 | EXP | PHHY2016BR074009 | NOVARTIS | 68.76 | YR | F | Y | 78.00000 | KG | 20160811 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124176373 | 12417637 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, QD | Y | 22527 | CAPSULE | QD | |||||||
| 124176373 | 12417637 | 2 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, QOD | Y | 22527 | CAPSULE | ||||||||
| 124176373 | 12417637 | 3 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, QD | Y | 22527 | CAPSULE | QD | |||||||
| 124176373 | 12417637 | 4 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, 3 TIMES A WEEK | Y | 22527 | CAPSULE | TIW | |||||||
| 124176373 | 12417637 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 1 DF (20 MG), QD (IN THE MORNING) | 0 | 1 | DF | TABLET | QD | ||||||
| 124176373 | 12417637 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | TABLET | |||||||||||
| 124176373 | 12417637 | 7 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Unknown | 0.5 DF, Q12H (MORNING AND NIGHT) | U | 0 | .5 | DF | TABLET | Q12H | |||||
| 124176373 | 12417637 | 8 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Unknown | 1 DF, QD (AT 08:00 AM) | U | 0 | 1 | DF | TABLET | QD | |||||
| 124176373 | 12417637 | 9 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | U | 0 | TABLET | ||||||||||
| 124176373 | 12417637 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | Endocervical | 1 DF, BID (1 TABLET AT 08:00 AM AND 1 AT 08:00 PM) | U | 0 | 1 | DF | TABLET | BID | |||||
| 124176373 | 12417637 | 11 | C | TRADJENTA | LINAGLIPTIN | 1 | Unknown | 1 DF, QD (AT 08:00 AM) | U | 0 | 1 | DF | TABLET | QD | |||||
| 124176373 | 12417637 | 12 | C | DEPURA | CHOLECALCIFEROL | 1 | Unknown | 2 DF, UNK | U | 0 | 2 | DF | DROPS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124176373 | 12417637 | 1 | Multiple sclerosis |
| 124176373 | 12417637 | 5 | Prophylaxis |
| 124176373 | 12417637 | 6 | Gastric disorder |
| 124176373 | 12417637 | 7 | Blood pressure abnormal |
| 124176373 | 12417637 | 8 | Urinary tract disorder |
| 124176373 | 12417637 | 9 | Diuretic therapy |
| 124176373 | 12417637 | 10 | Cardiac disorder |
| 124176373 | 12417637 | 11 | Diabetes mellitus |
| 124176373 | 12417637 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124176373 | 12417637 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124176373 | 12417637 | Anaemia | |
| 124176373 | 12417637 | Arthritis | |
| 124176373 | 12417637 | Asthenia | |
| 124176373 | 12417637 | Balance disorder | |
| 124176373 | 12417637 | Body height decreased | |
| 124176373 | 12417637 | Cataract | |
| 124176373 | 12417637 | Chills | |
| 124176373 | 12417637 | Cough | |
| 124176373 | 12417637 | Decreased interest | |
| 124176373 | 12417637 | Depressed mood | |
| 124176373 | 12417637 | Dizziness | |
| 124176373 | 12417637 | Emotional disorder | |
| 124176373 | 12417637 | Eyelid disorder | |
| 124176373 | 12417637 | Fall | |
| 124176373 | 12417637 | Gastrointestinal infection | |
| 124176373 | 12417637 | General physical health deterioration | |
| 124176373 | 12417637 | Gluten sensitivity | |
| 124176373 | 12417637 | Hypersensitivity | |
| 124176373 | 12417637 | Insomnia | |
| 124176373 | 12417637 | Lactose intolerance | |
| 124176373 | 12417637 | Malaise | |
| 124176373 | 12417637 | Memory impairment | |
| 124176373 | 12417637 | Multiple sclerosis | |
| 124176373 | 12417637 | Myelodysplastic syndrome | |
| 124176373 | 12417637 | Pneumonia | |
| 124176373 | 12417637 | Prescribed underdose | |
| 124176373 | 12417637 | Pruritus | |
| 124176373 | 12417637 | Raynaud's phenomenon | |
| 124176373 | 12417637 | Rheumatic disorder | |
| 124176373 | 12417637 | Rhinitis | |
| 124176373 | 12417637 | Skin discolouration | |
| 124176373 | 12417637 | Sluggishness | |
| 124176373 | 12417637 | Spinal cord herniation | |
| 124176373 | 12417637 | Spinal osteoarthritis | |
| 124176373 | 12417637 | Swelling | |
| 124176373 | 12417637 | Urinary tract infection | |
| 124176373 | 12417637 | Visual impairment | |
| 124176373 | 12417637 | Weight fluctuation | |
| 124176373 | 12417637 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |